VOGLIOS M2

VOGLIOS M2 is a combination anti-diabetic medication containing Voglibose 0.2 mg and Metformin 500 mg, formulated for the effective management of Type 2 Diabetes Mellitus. This dual-action therapy helps control post-prandial (after-meal) blood sugar levels while improving overall insulin sensitivity.

Key Benefits 

• Controls post-meal blood sugar spikes
• Improves insulin sensitivity
• Reduces hepatic glucose production
• Supports long-term glycemic control
• Suitable for combination therapy in Type 2 diabetes